Status: Not yet recruiting
CD34+ Transplants for Leukemia and Lymphoma
This study will evaluate whether processing blood stem cell transplants using an investigational device (the CliniMACS system) results in less complications for patients undergoing transplant for treatment of a blood malignancy (cancer) or blood disorder.
Participants needed: 100
Trial details
Phase: Phase 2Age: 18-74Biological sex: AllType: InterventionalSponsor: Guenther KoehneUpdated: Mar 3, 2026Locations: 1
Eligibility criteria
AML in 1st remission - for patients who is AML does not have 'good risk' cytogen... [+10]
Female patients who are pregnant or breast-feeding [+3]